Less Than Ideal: How Oncologists Practice With Limited Drug Access-Reference-Cited by-同舟云学术

Less Than Ideal: How Oncologists Practice With Limited Drug Access

Published:2012-05 Issue:3 Volume:8 Page:190-195
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Chan Kelvin K.¹,Wong Bertha¹,Siu Lillian L.¹,Straus Sharon E.¹,Chang José¹,Berry Scott R.¹

Affiliation:

1. Sunnybrook Odette Cancer Centre; Princess Margaret Hospital, University Health Network; University of Toronto; Li Ka Shing Knowledge Institute of St. Michael's Hospital; and RS McLaughlin Durham Regional Cancer Centre, Oshawa, Toronto, Ontario, Canada

Abstract

Canadian medical oncologists are struggling to provide optimal care for their patients with metastatic colorectal cancer as a result of differential access to preferred therapeutic drugs.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2011.000337

Reference24 articles.

1. Meta-Analysis of Survival of Patients with Stage IV Colorectal Cancer Managed with Surgical Resection Versus Chemotherapy Alone

2. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

3. Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Updated Results From the BICC-C Study

4. Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer

5. Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Response and Safety of Bevacizumab-awwb treatment in Patients with Metastatic Colorectal Cancer: A case series and review of the literature;2022-09-19

2. Patients’ and oncologists’ perceptions towards the discussion on high-cost innovative cancer therapies: findings from a qualitative study;BMJ Open;2022-09

3. Current Attitudes toward Unfunded Cancer Therapies among Canadian Medical Oncologists;Current Oncology;2021-11-16

5. Rationing cancer treatment: a qualitative study of perceptions of legitimate limit-setting;BMC Health Services Research;2018-05-09